Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth. [PDF]
, 1985 G Forni +2 more
openalex +1 more source
Regulation of lymphokine production in experimental and human chagas' disease
Memorias do Instituto Oswaldo Cruz, 1988 Rick L. Tarleton
doaj +1 more source
Production of a T cell hybridoma that expresses the T cell receptor gamma/delta heterodimer. [PDF]
, 1987 We have produced a T cell hybridoma line by fusion of an IL-2-dependent, long-term T cell receptor (TCR) gamma/delta+ Thy-1+, bone marrow-derived, dendritic epidermal cell line to the BW5147 tumor line.
Bluestone, JA +5 more
core
Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations. [PDF]
, 1987 Zuhair K. Ballas +2 more
openalex +1 more source
Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells. [PDF]
Oncol Rep, 2023 Kimura K +5 more
europepmc +1 more source
Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions [PDF]
, 1989 W Hinterberger +9 more
openalex +1 more source
Extensive hepatic cell necrosis produced by a lymphokine and its partial characterization.
, 1988 T Komada, T Nakajima, N Kitami
openalex +2 more sources
Regional administration of lymphokine-activated killer cells can be superior to intravenous application [PDF]
, 1992 Ulrich Keilholz +9 more
openalex +1 more source
Interleukine-2 serum level in breast cancer patients. [PDF]
Caspian J Intern Med, 2023 Harjianti T +4 more
europepmc +1 more source